Is sodium valproate, an HDAC inhibitor, associated with reduced risk of stroke and myocardial infarction? A nested case-control study
about
Epigenetic Regulation of Oxidative Stress in Ischemic StrokeHistone Deacetylase (HDAC) Inhibitors - emerging roles in neuronal memory, learning, synaptic plasticity and neural regenerationHistone deacetylases and cardiovascular cell lineage commitment.Antiepileptic drugs and the risk of ischaemic stroke and myocardial infarction: a population-based cohort studyThe relationship between prior antimicrobial prescription and meningitis: a case-control study.Mechanisms and treatment of ischaemic stroke--insights from genetic associations.Post-epilepsy stroke: A review.Illuminating drug action by network integration of disease genes: a case study of myocardial infarction.Patterns of anti-inflammatory drug use and risk of dementia: a matched case-control study.Factors influencing the development of primary care data collection projects from electronic health records: a systematic review of the literature.Sodium Valproate, a Histone Deacetylase Inhibitor, Is Associated With Reduced Stroke Risk After Previous Ischemic Stroke or Transient Ischemic Attack.Valproic acid selectively increases vascular endothelial tissue-type plasminogen activator production and reduces thrombus formation in the mouse.Valproic acid: a relevant thromboprophylactic strategy?Dual mechanisms for the regulation of brain-derived neurotrophic factor by valproic acid in neural progenitor cells
P2860
Q26743597-16ED7D54-0E06-4498-9C65-5B42C889DAD3Q28080593-46CDCB62-C1B9-43A9-9383-E5B5BA499FF6Q35774293-97523D64-AA4E-4550-B3AA-5DF4362FDB8FQ35960111-5D724257-42A4-4AA0-B1ED-F975F747EB0CQ36734283-AC84984A-4204-4C54-9138-8EB4AC9340AFQ38263023-CD4AB113-CB42-45AE-BF5B-972A960DDA37Q38751494-B821DE33-55CF-4763-9247-2861BD05C7A1Q40672660-9FA73C59-DA5D-4E40-AEAE-DDA35F348985Q40734133-3D4A8442-997D-4435-B9FB-99B5A7CB3CADQ42363908-9977DD6F-0EAD-4E38-BF09-7EBF223FCB80Q47299769-06FEDEAA-B33A-4334-9FC5-E37E6C35D0DAQ48487114-E7FF51D2-3FE7-4E02-8DD0-5904B6D2EA75Q49011295-1070314E-A7D6-4ED4-B95F-22BCA17191FEQ58565218-D740F036-B343-4242-918C-ADDDE6D6B5BA
P2860
Is sodium valproate, an HDAC inhibitor, associated with reduced risk of stroke and myocardial infarction? A nested case-control study
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Is sodium valproate, an HDAC i ...... n? A nested case-control study
@ast
Is sodium valproate, an HDAC i ...... n? A nested case-control study
@en
Is sodium valproate, an HDAC i ...... n? A nested case-control study
@nl
type
label
Is sodium valproate, an HDAC i ...... n? A nested case-control study
@ast
Is sodium valproate, an HDAC i ...... n? A nested case-control study
@en
Is sodium valproate, an HDAC i ...... n? A nested case-control study
@nl
prefLabel
Is sodium valproate, an HDAC i ...... n? A nested case-control study
@ast
Is sodium valproate, an HDAC i ...... n? A nested case-control study
@en
Is sodium valproate, an HDAC i ...... n? A nested case-control study
@nl
P2860
P50
P3181
P356
P1476
Is sodium valproate, an HDAC i ...... n? A nested case-control study
@en
P2093
Hugh S Markus
Judith Charlton
P2860
P304
P3181
P356
10.1002/PDS.3651
P407
P577
2014-07-01T00:00:00Z